RACHEL CALAMARI: Open Payments
NPI 1760108146 · SWEDESBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 31 payments from 5 companies in 2025. Trend: 2023 $361 · 2024 $1,180 · 2025 $703
Food & beverage: $635Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $429 |
| GENZYME CORPORATION | 1 | $123 |
| ABBVIE INC. | 5 | $94 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Amgen Inc. | 1 | $21 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Sotyktu, OTEZLA.
Industry payments across NJ — which companies pay providers there.
